艾克美制药
ALKS
41.22
+1.12
+2.79%
艾克美制药
US · ALKS
#1780 按市值排名
上市于 1970
41.22
+1.12
+2.79%
实时 - 追踪5344个代码 - 心跳于184秒前
· 2026-10-16 19:53
最新新闻
-
公司公告
4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.SEC · 2026/8/4
-
公司公告
4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.SEC · 2026/6/2
-
公司公告
Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.SEC · 2026/5/2
-
公司公告
4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.SEC · 2026/7/2
-
公司公告
Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.SEC · 2026/4/2
-
Mizuho Securities Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $65\u5e02\u573a\u8d44\u8baf · 2026/9/5
-
A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $38 to $65\u5e02\u573a\u8d44\u8baf · 2026/9/22
-
Goldman Sachs Initiates Alkermes(ALKS.US) With Hold Rating, Announces Target Price $50\u5e02\u573a\u8d44\u8baf · 2026/9/24
-
评级变动
J.P. Morgan Maintains Alkermes(ALKS.US) With Hold Rating, Raises Target Price to $60\u5e02\u573a\u8d44\u8baf · 2026/7/13
-
A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $56 to $83\u5e02\u573a\u8d44\u8baf · 2026/9/23
-
评级变动
Needham Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $62\u5e02\u573a\u8d44\u8baf · 2026/7/13
-
评级变动
TD Cowen Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $57\u5e02\u573a\u8d44\u8baf · 2026/7/13
-
评级变动
Piper Sandler Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $65\u5e02\u573a\u8d44\u8baf · 2026/8/6
-
评级变动
Stifel Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $63\u5e02\u573a\u8d44\u8baf · 2026/7/20
-
评级变动
Jefferies Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $78\u5e02\u573a\u8d44\u8baf · 2026/9/17
-
评级变动
Piper Sandler Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $65\u5e02\u573a\u8d44\u8baf · 2026/7/28
-
评级变动
A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $58 to $65\u5e02\u573a\u8d44\u8baf · 2026/7/30
-
Stifel Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $63\u5e02\u573a\u8d44\u8baf · 2026/10/5
-
评级变动
Jefferies Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $65\u5e02\u573a\u8d44\u8baf · 2026/7/9
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:53:58 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
艾克美制药 讨论区 0 条评论